Recommendations for Determining Risk of Hepatitis B Virus (HBV) Infection for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Draft Guidance for Industry
🏛 Food and Drug Administration (FDA)FDA-2022-D-0465
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.